Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Gelteq Ltd

  • Public · NASDAQ: GELS
  • 8 employees
$5.3MMarket cap
8Employees
GELSNASDAQ
2024IPO

About Gelteq Ltd

Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Market cap
$5.3M
NASDAQ: GELS

15-minute delayed · data by Polygon.io

Market cap
$5.3M
Open
Day range
Prev close
Volume
IPO date
Oct 29, 2024

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Gelteq Ltd.

Write a review
Explore

Similar companies

Browse all →